Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03880825 · ClinicalTrials.gov registry record · Phase 1
Drug Interaction Study of Levoketoconazole and Metformin
A Phase 1 study, sponsored by Cortendo AB.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT03880825: Completed Phase 1 study, sponsored by Cortendo AB.
NCT03880825 is a Phase 1 study that has completed, run by Cortendo AB. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03880825, a Phase 1 study, has completed, sponsored by Cortendo AB.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a phase I, open-label, fixed-sequence drug-drug interaction study to evaluate the effect of levoketoconazole on the single-dose PK of metformin in health subjects.
Primary Outcome
Maximum observed plasma concentration (Cmax) of metformin with and without concomitant administration of levoketoconazole.
Interventions
- DRUG Metformin 500 mg Oral Tablet
- DRUG Levoketoconazole 150 - 600 mg (BID)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-03-28 |
| Est. Completion | 2019-05-03 |
| Phase | Phase 1 |
What the finished NCT03880825 record still lists
NCT03880825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Metformin 500 mg Oral Tablet is the first listed.
NCT03880825 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03880825 about?
NCT03880825 is a clinical study titled "Drug Interaction Study of Levoketoconazole and Metformin". This is a phase I, open-label, fixed-sequence drug-drug interaction study to evaluate the effect of levoketoconazole on the single-dose PK of metformin in health subjects.
What is the current status of trial NCT03880825?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2019-03-28. Estimated completion is 2019-05-03.
What interventions are being tested in trial NCT03880825?
The interventions under investigation include: Metformin 500 mg Oral Tablet (DRUG), Levoketoconazole 150 - 600 mg (BID) (DRUG).
Who is sponsoring clinical trial NCT03880825?
This trial is sponsored by Cortendo AB, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03880825's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI